Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

75
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

215
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
215
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

523
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
523
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

93
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
93
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

101
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
101

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction Between Air Pollution and Genetic Predisposition to Blood Pressure and LDL-C on Cardiovascular Events.

European journal of preventive cardiology·2026
Same author

Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortality.

NPJ cardiovascular health·2026
Same author

Incidence and Risk Factors of Epilepsy Among Older Adults in the US Medicare Population.

JAMA neurology·2025
Same author

Retrospective analysis of disparities and excess mental health, opioid and alcohol mortality associated with the COVID-19 pandemic.

Journal of ethnicity in substance abuse·2025
Same author

The built environment and adverse cardiovascular events in US veterans with cardiovascular disease.

The Science of the total environment·2025
Same author

Distinct Cytokine Patterns Identify Acute and Convalescent Myocardial Involvement After Coronavirus Disease 2019: A Multicohort Biomarker Study.

The Journal of infectious diseases·2025

Related Experiment Video

Updated: Oct 23, 2025

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.1K

Ambient Air Pollution and Atherosclerosis: Recent Updates.

Graham H Bevan1,2, Sadeer G Al-Kindi1,2,3, Robert Brook4

  • 1Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Current Atherosclerosis Reports
|August 21, 2021
PubMed
Summary

Exposure to fine particulate matter (PM2.5) air pollution significantly increases cardiovascular disease risk. Long-term exposure accelerates atherosclerosis, posing a growing global public health concern.

Keywords:
Ambient air pollutionAtherosclerosis

More Related Videos

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

477
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.3K

Related Experiment Videos

Last Updated: Oct 23, 2025

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.1K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

477
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.3K

Area of Science:

  • Environmental Health
  • Cardiovascular Science
  • Toxicology

Background:

  • Particulate matter (PM) air pollution, specifically PM2.5, is a pervasive environmental exposure linked to adverse health outcomes.
  • Increased exposure to PM2.5 over the past century correlates with heightened cardiovascular (CV) morbidity and mortality.
  • Both short-term and long-term PM2.5 exposure detrimentally impact CV health, with chronic exposure posing a greater risk.

Purpose of the Study:

  • To review existing evidence on how ambient air pollution exposure precipitates cardiovascular events across different time frames.
  • To examine the association between PM2.5 exposure and atherosclerosis development and progression.
  • To synthesize findings from epidemiological and animal studies on air pollution's role in cardiovascular disease.

Main Methods:

  • Review of epidemiological studies investigating PM2.5 exposure and atherosclerosis markers.
  • Analysis of animal exposure experiments demonstrating chronic PM2.5 effects on atherosclerotic lesions.
  • Integration of human translational studies and mechanistic investigations.

Main Results:

  • Epidemiological data show a clear association between ambient PM2.5 exposure and the presence/progression of atherosclerosis.
  • Animal studies provide robust evidence that chronic PM2.5 exposure enhances atherosclerotic lesion progression and vulnerability.
  • Understanding of PM2.5's potentiation of atherosclerosis and cardiovascular events has improved through combined research.

Conclusions:

  • Ambient PM2.5 exposure is a significant contributor to atherosclerosis and cardiovascular events.
  • Long-term pro-atherosclerotic effects of PM2.5 are of substantial and increasing global public health importance.
  • Further research is needed to elucidate the role of specific PM constituents and modulating factors like immunity and the gut microbiome.